SkinVision - Detect Skin Cancer. Track your Moles.

DO YOU EVER WORRY ABOUT A SKIN SPOT?

SkinVision is a premium, paid for medical service that helps you assess skin spots and moles for the most common types of skin cancer. Take a photo with your smartphone and you receive a risk indication by our clinically validated technology within 30 seconds. We provide recommendations on the next steps to take, including whether to visit a healthcare professional.

You can use some features of SkinVision for free including: our risk profile and skin type quizzes, storing images of your moles and accessing UV information in your area.

Skin checks with our clinically validated technology are paid for. You can buy a single assessment or purchase unlimited checks for 3 or 12 months (no subscription).

Skin cancer is a global and growing problem. It's estimated that 1 in 5 people will develop it. More people are diagnosed with skin cancer each year than all other cancers combined. Because it can appear and grow over time, it’s important to monitor your skin and take photos of moles or spots regularly. Signs of skin cancer can include: irregular patterns, multiple colors, asymmetry, uneven borders, or changes in size, shape or colour over time.
Our checks use an algorithm to assess your mole or skin spot for signs of cancer. Our service is quality assured by our team of experts. Our users have performed more than 3.5 million checks and we’ve found over 40,000 cases of melanoma and other types of skin cancer.

The SkinVision app is a regulated medical device with European CE marking. We care about your privacy and are ISO certified for information security and medical device management. SkinVision is trusted by insurance companies worldwide for the early detection of skin cancer. SkinVision has partnerships with leading health insurers, cancer clinics and research universities in the United Kingdom, Australia, Germany, the Netherlands, and New Zealand.

More than 1 million people use SkinVision to monitor their moles and skin spots. Our mission is to save more than 250,000 lives in the next decade. Each photo helps us to improve the service and realize these goals. Are you ready to join?

Together we can reduce the impact of skin cancer.

Together we care.

WHY SKINVISION?
Monitoring spots can help you to detect skin cancer at an early stage when it’s more likely to be treatable. By using SkinVision, you can:

Check your skin for signs of skin cancer anytime, anywhere. This helps avoid unnecessary doctor visits
Receive a risk indication of your mole or skin spot (low, low (symptoms) or high) within 30 seconds
Store your photos in folders to help you track changes over time, or to share them with your doctor more easily
Learn about your skin with our information and get advice based on your skin type and risk profile
Buy single assessments, or purchase unlimited checks for 3 or 12 months
Contribute to SkinVision’s mission of saving lives


CONNECT WITH SKINVISION

Website - https://www.skinvision.com

Facebook - https://www.facebook.com/sknvsn

Twitter - https://twitter.com/sknvsn

Instagram - https://www.instagram.com/sknvsn/

If you have any questions or comments about the service, please contact us at info@skinvision.com.

DISCLAIMER:
The SkinVision service is not intended to replace traditional methods of evaluating skin cancer risk level, is not a diagnosis, and is not a substitute for visits to a healthcare professional. The SkinVision service is not intended for use on children.
Read more
Collapse
4.1
1,596 total
5
4
3
2
1
Loading…

Additional Information

Updated
June 24, 2020
Size
26M
Installs
100,000+
Current Version
5.17.2
Requires Android
4.4 and up
Content Rating
Everyone
Permissions
Offered By
SkinVision B.V.
Developer
Kraanspoor 28 1033 SE Amsterdam The Netherlands
©2020 GoogleSite Terms of ServicePrivacyDevelopersArtistsAbout Google|Location: United StatesLanguage: English (United States)
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.